Safeguarding capsule supply chains
For nutraceutical manufacturers, these trade rulings elevate the importance of supply chain transparency and proactive planning. Understanding supplier exposure, maintaining open communication on pricing and lead-time impacts, and diversifying sourcing strategies are critical steps to mitigate disruption.
With AD/CVD orders expected to remain in effect for at least five years—and many trade cases extending well beyond initial terms—companies that prioritize domestic manufacturing and resilient supply partnerships are better positioned to protect continuity and manage future uncertainty.
